Hohnloser, S. H. (2012). Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation. Clin Cardiol.
Chicago Style CitationHohnloser, Stefan H. "Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation." Clin Cardiol 2012.
Cita MLAHohnloser, Stefan H. "Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation." Clin Cardiol 2012.
Atenció: Aquestes cites poden no estar 100% correctes.